{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T04:09:22Z","timestamp":1746504562661,"version":"3.40.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["\/2025\/004"],"award-info":[{"award-number":["\/2025\/004"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bbrc.2025.151889","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T02:39:53Z","timestamp":1745548793000},"page":"151889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Vestigial-like family member 1 (VGLL1): An emerging candidate in tumor progression"],"prefix":"10.1016","volume":"766","author":[{"given":"Shubhashree","family":"Parimita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amitava","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjoy","family":"Samanta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.151889_bib1","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3389\/fonc.2020.01266","article-title":"Multiple roles of vestigial-like family members in tumor development","volume":"10","author":"Yamaguchi","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2025.151889_bib2","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1242\/dev.126.21.4807","article-title":"TONDU (TDU), a novel human protein related to the product of vestigial (vg) gene of Drosophila melanogaster interacts with vertebrate TEF factors and substitutes for Vg function in wing formation","volume":"126","author":"Vaudin","year":"1999","journal-title":"Development"},{"key":"10.1016\/j.bbrc.2025.151889_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/382133a0","article-title":"Integration of positional signals and regulation of wing formation and identity by Drosophila vestigial gene","volume":"382","author":"Kim","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.151889_bib4","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1101\/gad.12.24.3900","article-title":"The vestigial and scalloped proteins act together to directly regulate wing-specific gene expression in drosophila","volume":"12","author":"Halder","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2025.151889_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2025.151889_bib6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41467-024-44780-8","article-title":"VGLL1 cooperates with TEAD4 to control human trophectoderm lineage specification","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.151889_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/ERC-13-0485","article-title":"VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer","volume":"21","author":"Castilla","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbrc.2025.151889_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118892","article-title":"VGLL1 phosphorylation and activation promotes gastric cancer malignancy via TGF-beta\/ERK\/RSK2 signaling","volume":"1868","author":"Im","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.bbrc.2025.151889_bib9","article-title":"N(6)-methyladenosine-modified VGLL1 promotes ovarian cancer metastasis through high-mobility group AT-hook 1\/Wnt\/beta-catenin signaling","volume":"27","author":"Li","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.bbrc.2025.151889_bib10","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1038\/s41467-020-19141-w","article-title":"Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers","volume":"11","author":"Bradley","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.151889_bib11","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.str.2012.04.004","article-title":"Structural and functional similarity between the Vgll1-TEAD and the YAP-TEAD complexes","volume":"20","author":"Pobbati","year":"2012","journal-title":"Structure"},{"key":"10.1016\/j.bbrc.2025.151889_bib12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cell.2005.06.007","article-title":"The hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating yorkie, the drosophila homolog of YAP","volume":"122","author":"Huang","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2025.151889_bib13","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.semcdb.2012.05.004","article-title":"The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian hippo pathway","volume":"23","author":"Hong","year":"2012","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2025.151889_bib14","article-title":"Vestigial-like 1 (VGLL1): an ancient co-transcriptional activator linking wing, placenta, and tumor development","volume":"1878","author":"Sonnemann","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.bbrc.2025.151889_bib15","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.3748\/wjg.v29.i16.2452","article-title":"Updates on global epidemiology, risk and prognostic factors of gastric cancer","volume":"29","author":"Yang","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2025.151889_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121923","article-title":"PI3K\/AKT\/beta-Catenin signaling regulates vestigial-like 1 which predicts poor prognosis and enhances malignant phenotype in gastric cancer","volume":"11","author":"Kim","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2025.151889_bib17","first-page":"251","article-title":"Gastric cancer: classification, histology and application of molecular pathology","volume":"3","author":"Hu","year":"2012","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.bbrc.2025.151889_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010376","article-title":"TNF-alpha secreted from macrophages increases the expression of prometastatic integrin alphaV in gastric cancer","volume":"24","author":"Hwang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.151889_bib19","doi-asserted-by":"crossref","first-page":"13066","DOI":"10.1074\/jbc.274.19.13066","article-title":"Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin\/stromelysin-1 cascade enhances tumor cell invasion","volume":"274","author":"Ramos-DeSimone","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.151889_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0167-4781(01)00215-9","article-title":"HMGI\/Y proteins: flexible regulators of transcription and chromatin structure","volume":"1519","author":"Reeves","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2025.151889_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/modpathol.2010.200","article-title":"Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists","volume":"24","author":"Badve","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbrc.2025.151889_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111120","article-title":"VGLL1 stabilization of cytoplasmic TAZ promotes EGFR expression and maintains tumor initiating cells in breast cancer independent of TEAD","volume":"118","author":"Parimita","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbrc.2025.151889_bib23","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.151889_bib24","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2025.151889_bib25","doi-asserted-by":"crossref","first-page":"860","DOI":"10.5858\/133.6.860","article-title":"Basal-like breast carcinoma: from expression profiling to routine practice","volume":"133","author":"Rakha","year":"2009","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.bbrc.2025.151889_bib26","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2025.151889_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157368","article-title":"Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection","volume":"11","author":"Lehmann","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.151889_bib28","article-title":"The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes","volume":"7","author":"Pereira","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.151889_bib29","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.151889_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrc2088","article-title":"Epidermal growth factor receptor mutations in lung cancer","volume":"7","author":"Sharma","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2025.151889_bib31","first-page":"4","article-title":"Epidermal growth factor receptor inhibition strategies in pancreatic cancer: past, present and the future","volume":"8","author":"Cohenuram","year":"2007","journal-title":"JOP"},{"key":"10.1016\/j.bbrc.2025.151889_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-0-387-74039-3_8","article-title":"EGF receptor in breast cancer chemoresistance","volume":"608","author":"Dickson","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbrc.2025.151889_bib33","doi-asserted-by":"crossref","first-page":"S503","DOI":"10.21037\/tcr.2019.06.50","article-title":"Morphological and pathological features of basal-like breast cancer","volume":"8","author":"Botti","year":"2019","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.bbrc.2025.151889_bib34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.soc.2021.11.006","article-title":"Targeted therapy for colorectal cancer","volume":"31","author":"Sakata","year":"2022","journal-title":"Surg. Oncol. Clin."},{"key":"10.1016\/j.bbrc.2025.151889_bib35","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1158\/0008-5472.CAN-24-0013","article-title":"Induction of the TEAD coactivator VGLL1 by estrogen receptor-targeted therapy drives resistance in breast cancer","volume":"84","author":"Gemma","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2025.151889_bib36","article-title":"EGFR and EGFRvIII coopt host defense pathways, promoting progression in glioblastoma","author":"An","year":"2024","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbrc.2025.151889_bib37","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1200\/JCO.2003.11.069","article-title":"Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis","volume":"21","author":"Hirsch","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2025.151889_bib38","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1101\/gad.1536007","article-title":"Hippo signaling in organ size control","volume":"21","author":"Pan","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2025.151889_bib39","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.devcel.2010.09.011","article-title":"The hippo signaling pathway in development and cancer","volume":"19","author":"Pan","year":"2010","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbrc.2025.151889_bib40","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/j.celrep.2018.04.113","article-title":"IMP3 stabilization of WNT5B mRNA facilitates TAZ activation in breast cancer","volume":"23","author":"Samanta","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2025.151889_bib41","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2123134119","article-title":"Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers","volume":"119","author":"Soyama","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2025.151889_bib42","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cell.2015.07.013","article-title":"Alternative wnt signaling activates YAP\/TAZ","volume":"162","author":"Park","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2025.151889_bib43","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2025.151889_bib44","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.ejca.2006.01.031","article-title":"Breast cancer stem cells: an overview","volume":"42","author":"Ponti","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbrc.2025.151889_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.drup.2010.08.001","article-title":"The role of tumor initiating cells in drug resistance of breast cancer: implications for future therapeutic approaches","volume":"13","author":"Lacerda","year":"2010","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.bbrc.2025.151889_bib46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2009.12.007","article-title":"Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content","volume":"140","author":"Pece","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2025.151889_bib47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41573-023-00846-8","article-title":"Therapeutic targeting of the functionally elusive TAM receptor family","volume":"23","author":"Miao","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2025.151889_bib48","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000985","article-title":"The AXL-PYK2-PKCalpha axis as a nexus of stemness circuits in TNBC","volume":"4","author":"Khera","year":"2021","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.bbrc.2025.151889_bib49","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1073\/pnas.0909333107","article-title":"Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival","volume":"107","author":"Gjerdrum","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2025.151889_bib50","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/bcr2635","article-title":"Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer","volume":"12","author":"Prat","year":"2010","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbrc.2025.151889_bib51","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2006.01.013","article-title":"X chromosomal abnormalities in basal-like human breast cancer","volume":"9","author":"Richardson","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2025.151889_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrd.2016.211","article-title":"Induced protein degradation: an emerging drug discovery paradigm","volume":"16","author":"Lai","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2025.151889_bib53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of pancreatic cancer: global trends, etiology and risk factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"key":"10.1016\/j.bbrc.2025.151889_bib54","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11517-024-03210-z","article-title":"Integrated analysis of gene expressions and targeted mirnas for explaining crosstalk between oral and esophageal squamous cell carcinomas through an interpretable machine learning approach","volume":"63","author":"Yadav","year":"2025","journal-title":"Med. Biol. Eng. Comput."},{"key":"10.1016\/j.bbrc.2025.151889_bib55","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.18347","article-title":"COADREADx: a comprehensive algorithmic dissection of colorectal cancer unravels salient biomarkers and actionable insights into its discrete progression","volume":"12","author":"Palaniappan","year":"2024","journal-title":"PeerJ"},{"key":"10.1016\/j.bbrc.2025.151889_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01945-19","article-title":"The transcriptional cofactor VGLL1 drives transcription of human papillomavirus early genes via TEAD1","volume":"94","author":"Mori","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2025.151889_bib57","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/gcc.22823","article-title":"A novel EWSR1-VGLL1 gene fusion in a soft tissue malignant myoepithelial tumor","volume":"59","author":"Komatsu","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bbrc.2025.151889_bib58","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/cge.13703","article-title":"Novel EWSR1-VGLL1 fusion in a pediatric neuroepithelial neoplasm","volume":"97","author":"Kundishora","year":"2020","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bbrc.2025.151889_bib59","first-page":"45","article-title":"Regorafenib. Recent results","volume":"211","author":"Ettrich","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2025.151889_bib60","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1634\/theoncologist.2010-0035","article-title":"Trastuzumab","volume":"16","author":"Boekhout","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.bbrc.2025.151889_bib61","first-page":"217","article-title":"Olaparib. Recent results","volume":"211","author":"Bochum","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2025.151889_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.655316","article-title":"Angiogenesis inhibitors in small cell lung cancer","volume":"11","author":"Montanino","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2025.151889_bib63","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-genet-120417-031621","article-title":"The hippo signaling network and its biological functions","volume":"52","author":"Misra","year":"2018","journal-title":"Annu. Rev. Genet."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25006035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25006035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:15:14Z","timestamp":1746490514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25006035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":63,"alternative-id":["S0006291X25006035"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151889","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vestigial-like family member 1 (VGLL1): An emerging candidate in tumor progression","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151889","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151889"}}